Xembify, a 20% concentration SCIg product supplied by Grifols Australia, will be available for supply under the national blood arrangements from January 2024.
Patient blood management guideline for adults with critical bleeding (guideline) was published electronically on 10 August 2023 on MAGICapp - a web-based platfo
The Therapeutic Goods Administration (TGA) recently approved a submission from the Australian Red Cross Lifeblood (Lifeblood) to reduce the deferral period for
The Therapeutic Goods Administration (TGA) approved submissions from the Australian Red Cross Lifeblood (Lifeblood) to remove the deferral period for donors who
